A Leading Carbon Negative Materials Company Origin Materials, Inc. (NASDAQ: ORGN) is a premier material-technology Company focused on facilitating the world’s transition to sustainable materials. The Company has developed a leading-edge platform that can transform the carbon found in biomass into valuable products while capturing carbon...
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) develops Anticalin-based drugs for treatment of conditions related to immuno-oncology and respiratory diseases such as Asthma and Anaemia. Anticalin proteins are engineered versions of lipocalins that are human proteins having the ability to bind, store and transport molecules, which the Company has...
Anavex Life Sciences Corp (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company that is developing a pipeline of therapeutic candidates that target the Central Nervous System (CNS) by leveraging its expertise in precision genetic medicine. The Company has announced that its predictive biomarker of response established...
Graybug Vision, Inc. (NASDAQ: GRAY) is a clinical-stage biopharmaceutical company that is striving to create novel treatment solutions for diseases that combat vision—threatening diseases and save sight delivering a much better quality of life for patients. The Company is developing therapies for treatment of chronic...
